Tony Mollica steps into leadership role for Sun Life's dental business operations.

  • Tony Mollica becomes the new dental business leader at Sun Life US
  • This appointment aims to strengthen Sun Life’s dental service offerings
  • Mollica brings over 20 years of experience in the industry

Tony Mollica has been appointed as the new dental business leader at Sun Life US, where he will oversee their dental service operations. His leadership is expected to enhance the available offerings in Sun Life's dental portfolio. Mollica joins the company with over two decades of experience in the dental and insurance sectors, aiming to drive growth and innovation.

Throughout his career, Mollica has held various leadership roles that have contributed to the development of comprehensive dental solutions. His expertise includes fostering relationships with agents and partners, allowing for improved client engagement and satisfaction in dental services. This transition in leadership is poised to align with Sun Life’s goals of expanding their health service offerings.

Mollica's considerable background enables him to bring new perspectives to the role, which will be crucial in navigating the current landscape of dental insurance. As he steps into this position, there is anticipation about how he will leverage his industry knowledge to enhance service delivery for Sun Life’s clients.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Innovative automation enhances cancer research and immunological studies. AI-powered tools improve research…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

Services PMI at 53.8 in January 2026, According to ISM Report

January sees strong growth in services sector as PMI remains robust. Services…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…